Therapeutic Potential of Melatonin: Multifaceted Applications in Muscle Health, Metabolic Disorders and Cardiovascular Disease
DOI:
https://doi.org/10.12775/QS.2024.31.55921Keywords
melatonin, melatonin therapy, muscle regeneration, heart failure prevention, fibromyalgia treatment, type 2 diabetes, oxidative stress reductionAbstract
Melatonin, a hormone primarily synthesized by the pineal gland, is traditionally associated with the regulation of circadian rhythms. However, recent research has unveiled its broad spectrum of biological effects, positioning it as a valuable therapeutic agent in diverse health contexts. Known for its potent antioxidant and anti-inflammatory properties, melatonin plays a crucial role in maintaining homeostasis and protecting cellular integrity. This review explores melatonin’s therapeutic applications across multiple medical domains, including muscle health, metabolic disorders, chronic pain management, and cardiovascular health. In muscle health, melatonin facilitates muscle hypertrophy and regeneration by mitigating oxidative stress and enhancing the activity of satellite cells responsible for muscle repair. This action is particularly beneficial for individuals undergoing intense physical exertion, recovering from injuries, or combating age-related muscle. In metabolic disorders, such as type 2 diabetes, melatonin improves insulin sensitivity and reduces cellular oxidative damage, which supports beta-cell function and glucose regulation, potentially minimizing diabetes-related complications. Furthermore, in fibromyalgia - a condition marked by widespread pain and sleep disturbances - melatonin has demonstrated efficacy in alleviating pain and improving sleep quality, thus enhancing the overall quality of life for patients. In cardiovascular health, melatonin has shown promise in preventing and managing heart failure by reducing oxidative damage, modulating inflammatory pathways, and supporting endothelial function, which collectively contribute to improved cardiac health and reduced disease progression. This comprehensive review underscores melatonin’s emerging role as an integrative therapeutic agent in modern medicine.
References
Favero G, Franco C, Stacchiotti A, Rodella LF, Rezzani R. Sirtuin1 Role in the Melatonin Protective Effects Against Obesity-Related Heart Injury. Front Physiol. 2020;11:103.
Chen B, You W, Shan T. The regulatory role of melatonin in skeletal muscle. J Muscle Res Cell Motil. 2020;41(2-3):191-8.
Jin H, Xie W, Hu P, Tang K, Wang X, Wu Y, et al. The role of melatonin in sarcopenia: Advances and application prospects. Exp Gerontol. 2021;149:111319.
Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014;56(4):371-81.
Garaulet M, Qian J, Florez JC, Arendt J, Saxena R, Scheer F. Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy. Trends Endocrinol Metab. 2020;31(3):192-204.
Lauritzen ES, Kampmann U, Smedegaard SB, Støy J. Effects of daily administration of melatonin before bedtime on fasting insulin, glucose and insulin sensitivity in healthy adults and patients with metabolic diseases. A systematic review and meta-analysis. Clinical Endocrinology. 2021;95(5):691-701.
Caumo W, Hidalgo MP, Souza A, Torres ILS, Antunes LC. Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity. J Pain Res. 2019;12:545-56.
Reiter RJ, Acuna-Castroviejo D, Tan DX. Melatonin therapy in fibromyalgia. Curr Pain Headache Rep. 2007;11(5):339-42.
Pourhanifeh MH, Dehdashtian E, Hosseinzadeh A, Sezavar SH, Mehrzadi S. Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties. Cardiovasc Drugs Ther. 2022;36(1):131-55.
Zhou H, Ma Q, Zhu P, Ren J, Reiter RJ, Chen Y. Protective role of melatonin in cardiac ischemia-reperfusion injury: From pathogenesis to targeted therapy. J Pineal Res. 2018;64(3).
Hardeland R. Melatonin and inflammation-Story of a double-edged blade. J Pineal Res. 2018;65(4):e12525.
Stacchiotti A, Favero G, Rodella LF. Impact of Melatonin on Skeletal Muscle and Exercise. Cells. 2020;9(2).
León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res. 2005;38(1):1-9.
Milczarek R, Hallmann A, Sokołowska E, Kaletha K, Klimek J. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res. 2010;49(2):149-55.
Wang Y, Guo W, Xu H, Tang K, Zan L, Yang W. Melatonin suppresses milk fat synthesis by inhibiting the mTOR signaling pathway via the MT1 receptor in bovine mammary epithelial cells. J Pineal Res. 2019;67(3):e12593.
Jiménez-Aranda A, Fernández-Vázquez G, Campos D, Tassi M, Velasco-Perez L, Tan DX, et al. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res. 2013;55(4):416-23.
Almendros-Ruiz A, Lopez-Moro A, Conde-Pipò J, Santalla A, Requena B, Mariscal-Arcas M. The Effects of Melatonin Supplementation on Professional Football Player Performance: A Systematic Review. Nutrients. 2023;15(20).
Khatoon R, Sarkar, S., Chattopadhyay, A., Bandyopadhyay, D. The cardioprotective potential of melatonin on cardiac hypertrophy: A mechanistic overview. Melatonin Research 2023.
Lee S, Shin J, Hong Y, Lee M, Kim K, Lee SR, et al. Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats. Lab Anim Res. 2012;28(1):47-54.
Mendes C, Lopes AM, do Amaral FG, Peliciari-Garcia RA, Turati Ade O, Hirabara SM, et al. Adaptations of the aging animal to exercise: role of daily supplementation with melatonin. J Pineal Res. 2013;55(3):229-39.
Xu L, Li D, Li H, Zhang O, Huang Y, Shao H, et al. Suppression of obesity by melatonin through increasing energy expenditure and accelerating lipolysis in mice fed a high-fat diet. Nutr Diabetes. 2022;12(1):42.
Chahbouni M, Escames G, Venegas C, Sevilla B, García JA, López LC, et al. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J Pineal Res. 2010;48(3):282-9.
Su CM, Tsai CH, Chen HT, Wu YS, Chang JW, Yang SF, et al. Melatonin improves muscle injury and differentiation by increasing Pax7 expression. Int J Biol Sci. 2023;19(4):1049-62.
Favero G, Trapletti V, Bonomini F, Stacchiotti A, Lavazza A, Rodella LF, et al. Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats. Int J Mol Sci. 2017;18(7).
Park JH, Chung EJ, Kwon HJ, Im SS, Lim JG, Song DK. Protective effect of melatonin on TNF-α-induced muscle atrophy in L6 myotubes. J Pineal Res. 2013;54(4):417-25.
Potes Y, Díaz-Luis A, Bermejo-Millo JC, Pérez-Martínez Z, de Luxán-Delgado B, Rubio-González A, et al. Melatonin Alleviates the Impairment of Muscle Bioenergetics and Protein Quality Control Systems in Leptin-Deficiency-Induced Obesity. Antioxidants (Basel). 2023;12(11).
Li SJ, Cheng WL, Kao YH, Chung CC, Trang NN, Chen YJ. Melatonin Inhibits NF-κB/CREB/Runx2 Signaling and Alleviates Aortic Valve Calcification. Front Cardiovasc Med. 2022;9:885293.
Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44(1):26-40.
McMullan CJ, Curhan GC, Schernhammer ES, Forman JP. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013;178(2):231-8.
García JA, Volt H, Venegas C, Doerrier C, Escames G, López LC, et al. Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice. Faseb j. 2015;29(9):3863-75.
Cipolla-Neto J, Amaral FGD. Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr Rev. 2018;39(6):990-1028.
González-Flores D, López-Pingarrón L, Castaño MY, Gómez M, Rodríguez AB, García JJ, et al. Melatonin as a Coadjuvant in the Treatment of Patients with Fibromyalgia. Biomedicines. 2023;11(7).
Hemati K, Amini Kadijani A, Sayehmiri F, Mehrzadi S, Zabihiyeganeh M, Hosseinzadeh A, et al. Melatonin in the treatment of fibromyalgia symptoms: A systematic review. Complement Ther Clin Pract. 2020;38:101072.
Hussain SA, Al K, II, Jasim NA, Gorial FI. Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res. 2011;50(3):267-71.
Fusco R, Siracusa R, D'Amico R, Peritore AF, Cordaro M, Gugliandolo E, et al. Melatonin Plus Folic Acid Treatment Ameliorates Reserpine-Induced Fibromyalgia: An Evaluation of Pain, Oxidative Stress, and Inflammation. Antioxidants (Basel). 2019;8(12).
Lawson K. Is there a role for melatonin in fibromyalgia? AIMS Molecular Science. 2019;6.
Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res. 2003;58(1):10-9.
Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin. J Pineal Res. 2008;44(1):16-25.
Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med. 2009;15(1-2):43-50.
Altun A, Ugur-Altun B. Melatonin: therapeutic and clinical utilization. Int J Clin Pract. 2007;61(5):835-45.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Martyna Dydyk, Jakub Wójcik, Ewa Błaszczak, Piotr Malinowski, Urszula Kopczyńska, Cezary Kopczyński, Kinga Gurdak, Martyna Michalska, Aleksander Małachowski, Aleksandra Zając
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 110
Number of citations: 0
